Editorial Calendar
JNCCN 2022 Editorial Calendar*
MONTH | NCCN GUIDELINES® | NCCN GUIDELINES® INSIGHTS |
January | Kidney Cancer | Multiple Myeloma |
February | Gastric Cancer | Myelodysplastic Syndromes |
March | T-Cell Lymphoma | Head and Neck Cancers |
April | Management of Immunotherapy-Related Toxicities | Hodgkin Lymphoma |
May | Non-Small Cell Lung Cancer | Hematopoietic Growth Factors |
June | Breast Cancer | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
July | Soft Tissue Sarcoma | Lung Cancer Screening |
August | Thyroid Carcinoma | Bladder Cancer |
September | Myeloproliferative Neoplasms | Ovarian Cancer |
October | Rectal Cancer | Survivorship |
November | Pediatric Aggressive Mature B-Cell Lymphomas | Gastrointestinal Stromal Tumors |
December | Pediatric Central Nervous System Cancers | Prostate Cancer |
*This schedule represents the best information currently available. NCCN reserves the right to alter the editorial calendar without notice.
JNCCN 2023 Editorial Calendar*
MONTH | NCCN GUIDELINES® | NCCN GUIDELINES® INSIGHTS |
January | Systemic Light Chain Amyloidosis | Central Nervous System Cancers |
February | Uterine Neoplasms | Hematopoietic Cell Transplantation |
March | Smoking Cessation | Prostate Cancer Early Detection |
April | Esophageal and Esophagogastric Junction Cancers | Non–Small Cell Lung Cancer |
May | Acute Myeloid Leukemia | Distress Management |
June | Anal Carcinoma | Breast Cancer |
July | Ampullary Adenocarcinoma | Hepatobiliary Cancers |
August | Adolescent & Young Adult Oncology | Survivorship |
September | Malignant Peritoneal Mesothelioma | Breast Cancer Screening and Diagnosis |
October | Prostate Cancer | Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic |
November | Basal Cell Carcinoma | B-Cell Lymphomas |
December | Multiple Myeloma | Cervical Cancer |
*This schedule represents the best information currently available. NCCN reserves the right to alter the editorial calendar without notice.